CYTEK BIOSCIENCES, INC. Purchase Obligation, to be Paid, Remainder of Fiscal Year
CYTEK BIOSCIENCES, INC. (CTKB) had Purchase Obligation, to be Paid, Remainder of Fiscal Year of $629.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2026-08-05
- 2026-06-30: Purchase Obligation, to be Paid, Remainder of Fiscal Year $629.00K.
- 2026-03-31: Purchase Obligation, to be Paid, Remainder of Fiscal Year $1.08M.
- 2025-09-30: Purchase Obligation, to be Paid, Remainder of Fiscal Year $588.00K.
- 2025-06-30: Purchase Obligation, to be Paid, Remainder of Fiscal Year $811.00K.
| Period end | Purchase Obligation, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $629.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.08M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $588.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $811.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.80M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $477.00K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |